- Home
- JAZZ vs LAD Comparison
JAZZ vs LAD Comparison
Compare JAZZ & LAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- LAD
- Stock Information
- Founded
- JAZZ 2003
- LAD 1946
- Country
- JAZZ Ireland
- LAD United States
- Employees
- JAZZ N/A
- LAD N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- LAD Retail-Auto Dealers and Gas Stations
- Sector
- JAZZ Health Care
- LAD Consumer Discretionary
- Exchange
- JAZZ Nasdaq
- LAD Nasdaq
- Market Cap
- JAZZ 7.1B
- LAD 7.4B
- IPO Year
- JAZZ 2007
- LAD 1996
- Fundamental
- Price
- JAZZ $124.15
- LAD $340.05
- Analyst Decision
- JAZZ Strong Buy
- LAD Strong Buy
- Analyst Count
- JAZZ 12
- LAD 13
- Target Price
- JAZZ $182.75
- LAD $383.38
- AVG Volume (30 Days)
- JAZZ 879.8K
- LAD 316.3K
- Earning Date
- JAZZ 08-05-2025
- LAD 10-22-2025
- Dividend Yield
- JAZZ N/A
- LAD 0.66%
- EPS Growth
- JAZZ N/A
- LAD 8.81
- EPS
- JAZZ N/A
- LAD 33.70
- Revenue
- JAZZ $4,086,695,000.00
- LAD $37,155,800,000.00
- Revenue This Year
- JAZZ $5.65
- LAD $4.45
- Revenue Next Year
- JAZZ $5.79
- LAD $4.49
- P/E Ratio
- JAZZ N/A
- LAD $9.82
- Revenue Growth
- JAZZ 4.52
- LAD 10.11
- 52 Week Low
- JAZZ $95.49
- LAD $255.32
- 52 Week High
- JAZZ $148.06
- LAD $405.68
- Technical
- Relative Strength Index (RSI)
- JAZZ 66.76
- LAD 66.81
- Support Level
- JAZZ $122.50
- LAD $302.50
- Resistance Level
- JAZZ $126.14
- LAD $341.00
- Average True Range (ATR)
- JAZZ 2.50
- LAD 7.82
- MACD
- JAZZ 0.80
- LAD 5.32
- Stochastic Oscillator
- JAZZ 87.44
- LAD 98.09
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About LAD Lithia Motors Inc.
Lithia Motors is a retailer of new and used vehicles and related services. The company offers over 50 brands of vehicles at nearly 500 stores globally across the US, Canada, and UK. The company has expanded largely through the acquisition of dealerships in smaller regional markets but now seeks to grow in any part of the US and we expect more deals over time in the US and, at times, abroad. Annual revenue in 2024 was $36.2 billion and we see over $50 billion possible in a few years. The US was 78% of 2024 revenue and the UK second at 19%, due to the 2024 Pendragon acquisition. In 2024, new vehicle sales were about 49% of total revenue. Lithia was founded in 1946, went public in 1996, and is the largest US auto dealer. It is based in Medford, Oregon.